Incyte and MorphoSys' antibody therapy tafasitamab has been approved in Europe, promising to provide a more convenient alternative to expensive and cumbersome CAR-T therapies for patients with ...

A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata. In a brief filing with the National Stock Exchange (NSE ...

Incyte had a net margin of 0.80% and a negative return on equity of 0.63%. The firm had revenue of $1.14 billion during the quarter, compared to analysts’ expectations of $1.08 billion.

Poscierre: January 31 at 5:16:55 PM EST ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

After hours: January 24 at 4:37:17 p.m. EST ...

Pharmaceutical company Incyte doubled its presence in Delaware when it purchased two historic office buildings in Downtown Wilmington last spring. The city’s real estate community was still ...